Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Advanced Biomed Inc. (ADVB : NSDQ)

• Company Description    Advanced Biomed Inc. is a biotechnology company focused on early screening and detection, diagnosis and staging and treatment of cancer. Advanced Biomed Inc. is based in Tainan, Taiwan. Number of Employees: 31

• Price / Volume Information    Yesterday's Closing Price: $3.95 Daily Weekly Monthly 20 Day Moving Average: 314,464 shares Shares Outstanding: 1.38 (millions) Market Capitalization: $5.46 (millions) Beta: 0.56 52 Week High: $24.80 52 Week Low: $3.61 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -38.95% -41.93% 12 Week -1.50% -8.94% Year To Date -32.32% -34.94%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 122 EAST 42ND STREET 18TH FLOOR - NEW YORK,NY 10168 USA ph: 86-21-2051-0823 fax: - alan@advanbiomed.com http://www.advanbiomed.com

• General Corporate Information    Officers Yi Lu - Chief Executive Officer and Chairman Mingze Yin - Chief Financial Officer Steven I-Fang Cheng - Director Jing Zhang - Director Cheang I Kei - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 00752P203 SIC: 8071 Fiscal Year Fiscal Year End: June Last Reported Quarter: 03/01/26 Next Expected EPS Date: - Share - Related Items Shares Outstanding: 1.38 Most Recent Split Date: 2.00 (0.05:1) Beta: 0.56 Market Capitalization: $5.46 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: -

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: 0.79 PEG Ratio: - Price Ratios Price/Book: 0.59 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 72.86% vs. Previous Quarter: -105.94% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 03/31/26 - 87.74 12/31/25 - 92.11 09/30/25 - -116.93 ROA 03/31/26 - 64.49 12/31/25 - 58.03 09/30/25 - -51.40 Current Ratio 03/31/26 - 7.38 12/31/25 - 8.56 09/30/25 - 1.92 Quick Ratio 03/31/26 - - 12/31/25 - 8.56 09/30/25 - 1.92 Operating Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Net Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Pre-Tax Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Book Value 03/31/26 - 6.66 12/31/25 - 8.76 09/30/25 - 2.78 Inventory Turnover 03/31/26 - - 12/31/25 - - 09/30/25 - - Debt-to-Equity 03/31/26 - 0.00 12/31/25 - 0.00 09/30/25 - 0.00 Debt-to-Capital 03/31/26 - 0.00 12/31/25 - 0.00 09/30/25 - 0.00

Powered by Zacks Investment Research ©